Skip to main content

Advertisement

SpringerLink
Log in

Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Aurora-A, a member of serine/threonine kinase, is implied in mitosis and centrosome maturation. Increasing levels of Aurora-A have been shown to be present in several malignancies and especially in bladder cancer. No immunohistochemical marker has shown to be able to predict the clinical outcome of patients with superficial bladder cancer, except MIB-1, as a predictive marker of relapse and progression. The aim was to investigate the expression of Aurora-A and MIB-1 in tissue micro arrays of superficial bladder cancer representative of pTa papillary urothelial neoplasm with different degrees of aggressiveness (low malignant potential [PUNLMP], non-invasive papillary urothelial carcinoma low grade [NILGC], non-invasive papillary urothelial carcinoma high grade [NIHGC] and carcinoma in situ). We analysed predictive values of both markers, their specificity and sensitivity in tumor recurrence. Aurora-A was a sensitive marker to predict tumor recurrence especially for pTa (PUNLMP, NILGC; PUNLMP p < 0.001, NILGC p < 0.001) with statistical significant correlation between immunohistochemical staining and clinical outcome. MIB-1 expression displayed statistical difference p = 0.002 in the PUNLMP group and p = 0.03 in the NILGC group. Aurora-A is a more sensitive marker than MIB-1 to predict relapse in pTa bladder neoplasias. The combination of both markers seems to have a very powerful predictive value of recurrence (p < 0.001).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Alsheikh A, Mohamedali Z, Jones E, Masterson J, Gilks CB (2001) Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/International Society of Urologic Pathology. Mod Pathol 14(4):267–272

    Article  PubMed  CAS  Google Scholar 

  2. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD et al (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392(6673):300–303

    Article  PubMed  CAS  Google Scholar 

  3. Chopin DK, Gattegno B (2002) Superficial bladder tumors. Eur Urol 42(6):533–541

    Article  PubMed  Google Scholar 

  4. Ducat D, Zheng Y (2004) Aurora kinases in spindle assembly and chromosome segregation. Exp Cell Res 301(1):60–67

    Article  PubMed  CAS  Google Scholar 

  5. Duchrow M, Schluter C, Wohlenberg C, Flad HD, Gerdes J (1996) Molecular characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67. Cell Prolif 29(1):1–12

    Article  PubMed  CAS  Google Scholar 

  6. Dybowski B, Kupryjanczyk J, Rembiszewska A, Pykalo R, Borkowski A (2003) P27(Kip1) and Ki-67 expression analysis in transitional cell carcinoma of the bladder. Urol Res 31(6):397–401

    Article  PubMed  CAS  Google Scholar 

  7. Dyrskjot L, Zieger K, Kruhoffer M, Thykjaer T, Jensen JL, Primdahl H et al (2005) A molecular signature in superficial bladder carcinoma predicts clinical outcome. Clin Cancer Res 11(11):4029–4036

    Article  PubMed  CAS  Google Scholar 

  8. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) Tumours of the urinary system and male genital organs. IARC, Lyon, France

    Google Scholar 

  9. Fraizer GC, Diaz MF, Lee IL, Grossman HB, Sen S (2004) Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. Int J Oncol 25(6):1631–1639

    PubMed  CAS  Google Scholar 

  10. Frank I, Cheville JC, Blute ML, Lohse CM, Karnes RJ, Weaver AL et al (2004) Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement. Cancer 101(8):1803–1808

    Article  PubMed  Google Scholar 

  11. Gattegno B, Chopin D (2001) Natural history of superficial bladder tumors. Prog Urol 11(5):963–990

    PubMed  CAS  Google Scholar 

  12. Gritsko TM, Coppola D, Paciga JE, Yang L, Sun M, Shelley SA et al (2003) Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res 9(4):1420–1426

    PubMed  CAS  Google Scholar 

  13. Helpap B (2001) Nonepithelial neoplasms of the urinary bladder. Virchows Arch 439(4):497–503

    Article  PubMed  CAS  Google Scholar 

  14. Helpap B, Schmitz-Drager BJ, Hamilton PW, Muzzonigro G, Galosi AB, Kurth KH et al (2003) Molecular pathology of non-invasive urothelial carcinomas (part I). Virchows Arch 442(4):309–316

    PubMed  CAS  Google Scholar 

  15. Holmang S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL (2001) Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 165(4):1124–1128, discussion 1128–1130

    Article  PubMed  CAS  Google Scholar 

  16. Holmang S, Johansson SL (2002) Stage Ta-T1 bladder cancer: the relationship between findings at first follow-up cystoscopy and subsequent recurrence and progression. J Urol 167(4):1634–1637

    Article  PubMed  Google Scholar 

  17. Jeng YM, Peng SY, Lin CY, Hsu HC (2004) Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 10(6):2065–2071

    Article  PubMed  CAS  Google Scholar 

  18. Jourdan F, Sebbagh N, Comperat E, Mourra N, Flahault A, Olschwang S et al (2003) Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch 443(2):115–121

    Article  PubMed  CAS  Google Scholar 

  19. Kamada K, Yamada Y, Hirao T, Fujimoto H, Takahama Y, Ueno M et al (2004) Amplification/overexpression of Aurora-A in human gastric carcinoma: potential role in differentiated type gastric carcinogenesis. Oncol Rep 12(3):593–599

    PubMed  CAS  Google Scholar 

  20. Knowles MA (2001) What we could do now: molecular pathology of bladder cancer. Mol Pathol 54(4):215–221

    Article  PubMed  CAS  Google Scholar 

  21. Lebret T, Bohin D, Kassardjian Z, Herve JM, Molinie V, Barre P et al (2000) Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette–Guerin instillations. J Urol 163(1):63–67

    Article  PubMed  CAS  Google Scholar 

  22. Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K et al (2003) Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 9(3):991–997

    PubMed  CAS  Google Scholar 

  23. Mai KT, Elmontaser G, Perkins DG, Yazdi HM, Stinson WA, Thijssen A (2004) Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma. BJU Int 94(4):544–547

    Article  PubMed  Google Scholar 

  24. Nocito A, Bubendorf L, Maria Tinner E, Suess K, Wagner U, Forster T et al (2001) Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 194(3):349–357

    Article  PubMed  CAS  Google Scholar 

  25. Reis-Filho JS, Simpson PT, Martins A, Preto A, Gartner F, Schmitt FC (2003) Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 443(2):122–132

    Article  PubMed  CAS  Google Scholar 

  26. Richter J, Jiang F, Gorog JP, Sartorius G, Egenter C, Gasser TC et al (1997) Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 57(14):2860–2864

    PubMed  CAS  Google Scholar 

  27. Sanchez-Carbayo M (2004) Recent advances in bladder cancer diagnostics. Clin Biochem 37(7):562–571

    Article  PubMed  CAS  Google Scholar 

  28. Sen S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, Ito S et al (2002) Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 94(17):1320–1329

    PubMed  CAS  Google Scholar 

  29. Shariat SF, Kim J, Raptidis G, Ayala GE, Lerner SP (2003) Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder. Urology 61(6):1140–1145

    Article  PubMed  Google Scholar 

  30. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT et al (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398(6729):714–718

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service Central d’Anatomie et Cytologie Pathologiques et d’Urologie, Hôpital La Pitié-Salpêtrière, 83, Bd de l’Hôpital, 75013, Paris, France

    E. Compérat, E. Chartier-Kastler, F. Richard & F. Capron

  2. Faculté de Pharmacie, Unité CNRS, UMR 8149, 4, Av de l’Observatoire, Paris V, France

    E. Compérat & V. Paradis

  3. Service Central d’Anatomie et Cytologie Pathologiques et d’Urologie, Département d’Epidemiologie et de Santé Publique Nord, Hôpital d’Instruction des Armées Val-de Grace, 74, boulevard Port Royal, 75230, Paris, France

    P. Camparo & R. Haus

  4. Service Central d’Anatomie et Cytologie Pathologiques, Groupe hospitalier Cochin-Saint Vincent de Paul, Faculté de médecine Paris V, 27, rue du Faubourg Saint Jaques, 75679, Paris, Cedex 14, France

    B. Radenen

Authors
  1. E. Compérat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Camparo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Haus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Chartier-Kastler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Radenen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Richard
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Capron
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V. Paradis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Compérat.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Compérat, E., Camparo, P., Haus, R. et al. Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms. Virchows Arch 450, 419–424 (2007). https://doi.org/10.1007/s00428-007-0383-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-007-0383-x

Keywords

Search

Navigation